Boltz
3 known investors
Boltz develops generative AI models for biomolecular design and drug discovery, used by researchers across pharmaceutical, biotech, agricultural, and academic sectors. The company offers frontier foundation models for protein and small-molecule design through an API with enterprise deployment options.
AI & Machine LearningBiotechDeep Tech
Investors · 3
In the news
- Boltz - 2026 Company Profile, Funding & Competitors - Tracxntracxn.com · 2026
- Boltz - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2026
- MIT Team Behind Boltz Launches With $28M, Pfizer Collaboration, and Three Guaranteesbiopharmatrend.com · 2026
- Boltz Bags $28M Funding and Pfizer Partnership for Biomolecular AI Boost - TechRepublictechrepublic.com · 2026
- Boltz takes off with $28M seed, partners with Pfizer on AI drug discovery | FirstWord Pharmafirstwordpharma.com · 2026
- Boltz raises $28M seed to build open AI models in biologyendpoints.news · 2026